Skip to content

Clinical trials

Myocardial Infarction trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Not applicable Clear all

574 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20014
20022
20038
20046
200511
20067
200714
200813
200920
201017
201120
201226
201322
201422
201524
201634
201734
201829
201927
202030
202128
202237
202342
202432
202522
202633

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed300
Unknown status105
Recruiting67
Active, not recruiting28
Terminated28
Not yet recruiting22
Withdrawn14
Enrolling by invitation8
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chonnam National University Hospital9
Medtronic Vascular9
University of Edinburgh8
Hospices Civils de Lyon7
Karolinska Institutet7
Mayo Clinic7
National Taiwan University Hospital6
Norwegian University of Science and Technology6
Riphah International University6
University Hospital, Bordeaux6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction574
Coronary Artery Disease116
ST Elevation Myocardial Infarction58
Acute Coronary Syndrome56
Cardiovascular Diseases54
Heart Failure45
Myocardial Ischemia44
Stroke42
Coronary Disease26
Angina Pectoris25

Trials

Showing 76 to 100 of 574. Each trial links to its page on Pharma Observatory.

474 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.